MedTrace Logo

Observational Study of Pediatric Rheumatic and Immunologic Diseases in China: The CAPRID Registry

NCT06417502 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 20000

Last updated 2024-05-16

No results posted yet for this study

Summary

An observational, multi-center, longitudinal registry study for Chinese pediatric patients with rheumatic and immunologic diseases.

Conditions

Sponsors & Collaborators

  • Children's Hospital of Chongqing Medical University

    collaborator OTHER

  • Central South University

    collaborator OTHER

  • Beijing Children's Hospital

    collaborator OTHER

  • Shenzhen Children's Hospital

    collaborator OTHER_GOV

  • Children's Hospital of Nanjing Medical University

    collaborator OTHER

  • The University of Hong Kong Shenzhen Institute of Research and Innovation (HKU-SIRI)

    collaborator UNKNOWN

  • Zhejiang University

    collaborator OTHER

  • Third Hospital of Peking University

    collaborator UNKNOWN

  • Peking Union Medical College Hospital

    lead OTHER

Principal Investigators

  • Hongmei Song, MD · Peking Union Medical College Hospital

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-29
Primary Completion
2024-11-30
Completion
2031-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06417502 on ClinicalTrials.gov